[Obesity in patients with diabetes].
Ohara
Takeshi
T
Division of Diabetes, Digestive and Kidney Diseases, Kobe University Graduate School of Medicine.
Kasuga
Masato
M
D000322:Adrenergic Agonists / Q000627:therapeutic use; D019440:Anti-Obesity Agents / Q000627:therapeutic use; D001521:Behavior Therapy; D003920:Diabetes Mellitus / Q000503:physiopathology* / Q000628:therapy*; D004038:Diet, Reducing; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D005081:Exercise Therapy; D015390:Gastric Bypass; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007783:Lactones / Q000627:therapeutic use; D008049:Lipase / Q000037:antagonists & inhibitors; D009765:Obesity; D000077403:Orlistat; D017366:Serotonin Receptor Agonists / Q000627:therapeutic use
D000322:Adrenergic Agonists; D019440:Anti-Obesity Agents; D004791:Enzyme Inhibitors; D007004:Hypoglycemic Agents; D007783:Lactones; D017366:Serotonin Receptor Agonists; D000077403:Orlistat; D008049:Lipase